A
Overview
Alleviate Health provides AI-powered recruitment tools for the healthcare sector. Its platform uses conversational AI to engage patients, screen for interest and fit, and quickly schedule qualified candidates for conversations with recruiters. The service is delivered as a subscription or licensing product that integrates into healthcare organizations’ hiring workflows. It differentiates itself by focusing on clinical recruitment and patient-facing screening, aiming to shorten recruiting cycles and improve the quality of recruiter-candidate conversations.
Work here?Claim your company
Simplify's take
What believers are saying
- Alleviate says it works with seven of the top fifteen U.S. site networks.
- Its October 2026 hiring posts show 100,000 monthly conversations and product expansion.
- Recruitment delays cost $600,000 to $8 million daily, creating urgent buyer demand.
What critics are saying
- The company is still seed-stage, raising only $4.3 million in October 2025.
- Clinical trial recruitment is crowded, with Antidote and SubjectWell already entrenched.
- If customers distrust AI screening accuracy, trial sites can drop Alleviate quickly.
What makes Alleviate Health unique
- Alleviate runs human-in-the-loop AI across SMS, voice, and email for trials.
- It claims 500,000+ patient interactions across 190+ sites since 2025.
- Its library of 150,000+ conversations should improve screening quality and conversion.
Help us improve and share your feedback! Did you find this helpful?
Funding
Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Industry standards
Ind Avg. $3.3M
$500k
$1.5M
$2M
$2.3M
$3M
$4.3M